Genomics Market Research Reports & Industry Analysis
Genomics is dedicated to the study, analysis, and application of genetic materials. As the field of genomics advances, its effects are felt across various industries including healthcare, biotechnology, and personalized medicine. MarketResearch.com offers comprehensive genomics industry reports to help you stay informed in this fast-growing industry.
Genomics Market Size and Analysis
- Our reports cover various genomics markets extensively, including genomics, proteomics, and cell biology technology.
- We provide in-depth insights into market dynamics, offering market size data, growth projections, and analysis of key technological innovations, industry trends, and competitor strategies.
- Additionally, our genomics research highlights emerging trends that could significantly impact the industry. Being aware of these trends is vital for long-term success in an ever-changing landscape.
Insights for Informed Decisions
Our genomics market research reports provide reliable data for making informed decisions, helping you increase revenue and capitalize on emerging opportunities. Our team of research specialists is on standby to assist you by providing tailored recommendations to fit your specific needs. As the genomics field evolves, count on MarketResearch.com for valuable insights to maintain your competitive edge.
Genomics Industry Research & Market Reports
-
Hereditary Testing
... CAGR of 6.2% over the analysis period 2024-2030. Preimplantation Genetic Diagnosis & Screening, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 Billion by the end ... Read More
-
Life Science Tools
... at a CAGR of 8.0% over the analysis period 2024-2030. Cell Biology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$84.6 Billion by the end of ... Read More
-
Predictive Diagnostics
... CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$821.4 Million While China is Forecast to Grow at 9.9% CAGR The Predictive Diagnostics market in the U.S. is estimated at ... Read More
-
Protein Extracts from Single Cell Protein and Other Conventional Sources
... Billion in the year 2024, is expected to reach US$44.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Plant Protein Extract, one of the segments analyzed in the report, ... Read More
-
Glycomics / Glycobiology
... at a CAGR of 16.9% over the analysis period 2024-2030. Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Ancestry and Relationship Testing
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Online, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$1.1 Billion by the end ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of the ... Read More
-
Nutrigenomics
... 16.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
Recombinant DNA Technology
... at a CAGR of 4.5% over the analysis period 2024-2030. Medical, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.9 Billion by the end of the ... Read More
-
Gene Amplification Technologies
... at a CAGR of 10.0% over the analysis period 2024-2030. Medical & Pharma, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.4 Billion by the end ... Read More
-
Human Identification
... CAGR of 7.7% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
microRNA (miRNA)
... CAGR of 13.1% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$411.8 Million by the end of the analysis period. ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Cloning, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Predictive Genetic Testing and Consumer Genomics
... reach US$20.7 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Predictive Testing, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach ... Read More
-
Spatial Genomics and Transcriptomics
... 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$320.3 Million by the end ... Read More
-
Gene Expression Analysis
... at a CAGR of 8.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Optogenetics Actuators and Sensors
... 2030, growing at a CAGR of 1.9% over the analysis period 2024-2030. Actuators, one of the segments analyzed in the report, is expected to record a 1.5% CAGR and reach US$405.4 Million by the end ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. ... Read More
-
Metabolomics
... 11.7% over the analysis period 2024-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$3.3 Billion by the end of the analysis period. ... Read More
-
Apoptosis
... 4.6% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More
Research Assistance
